Keeping It Local in Metabolic Disease: Adipose Tissue Paracrine Signaling and Insulin Resistance

Overview

Journal Diabetes

Specialty Endocrinology

Date 2022 Mar 22

PMID 35316835

Authors

Darcy E Kahn

Bryan C Bergman

Affiliations

Soon will be listed here.

Abstract

Alterations in adipose tissue composition and function are associated with obesity and contribute to the development of type 2 diabetes. While the significance of this relationship has been cemented, our understanding of the multifaceted role of adipose tissue in metabolic heath and disease continues to evolve and expand. Heterogenous populations of cells that make up adipose tissue throughout the body generate diverse secretomes containing a mosaic of bioactive compounds with vast structural and signaling capabilities. While there are many reports highlighting the important role of adipose tissue endocrine signaling in insulin resistance and type 2 diabetes, the direct, local, paracrine effect of adipose tissue has received less attention. Recent studies have begun to underscore the importance of considering anatomically discrete adipose depots for their specific impact on local microenvironments and metabolic function in neighboring tissues as well as regulation of whole-body physiology. This article highlights the important role of adipose tissue paracrine signaling on metabolic function and insulin sensitivity in nearby tissues and organs, specifically focusing on visceral, pancreatic, subcutaneous, intermuscular, and perivascular adipose tissue depots.

Citing Articles

Myopenia and body fat distribution in hospitalized ulcerative colitis patients: correlations with clinical characteristics and response to vedolizumab.

Wei W, Yan P, Zhang Y, Wang Q, Kang J, Liu P Front Nutr. 2025; 11:1411695.

PMID: 39758314 PMC: 11695233. DOI: 10.3389/fnut.2024.1411695.

Relationships between trunk tissue distribution, metabolic risk factors and physical performance in young people-A pilot study.

Ishiguro-Tanaka N, Kitagawa F, Akima H Clin Physiol Funct Imaging. 2024; 45(1).

PMID: 39709534 PMC: 11663261. DOI: 10.1111/cpf.12922.

Body composition derangements in lung cancer patients treated with first-line pembrolizumab: A multicentre observational study.

Trestini I, Belluomini L, Dodi A, Sposito M, Caldart A, Kadrija D J Cachexia Sarcopenia Muscle. 2024; 15(6):2349-2360.

PMID: 39439222 PMC: 11634481. DOI: 10.1002/jcsm.13568.

Association of daily carbohydrate intake with intermuscular adipose tissue in Korean individuals with obesity: a cross-sectional study.

Choi H, Kim Y, Yim J Nutr Res Pract. 2024; 18(1):78-87.

PMID: 38352215 PMC: 10861342. DOI: 10.4162/nrp.2024.18.1.78.

CD73-dependent generation of extracellular adenosine by vascular endothelial cells modulates lipogenesis in adipose tissue.

Jaeckstein M, Schulze I, Zajac M, Heine M, Mann O, Pfeifer A Front Immunol. 2024; 14:1308456.

PMID: 38264660 PMC: 10803534. DOI: 10.3389/fimmu.2023.1308456.

References

Fernandez-Alfonso M, Gil-Ortega M, Garcia-Prieto C, Aranguez I, Ruiz-Gayo M, Somoza B . Mechanisms of perivascular adipose tissue dysfunction in obesity. Int J Endocrinol. 2013; 2013:402053. PMC: 3838835. DOI: 10.1155/2013/402053. View

Chusyd D, Wang D, Huffman D, Nagy T . Relationships between Rodent White Adipose Fat Pads and Human White Adipose Fat Depots. Front Nutr. 2016; 3:10. PMC: 4835715. DOI: 10.3389/fnut.2016.00010. View

Girard J, Lafontan M . Impact of visceral adipose tissue on liver metabolism and insulin resistance. Part II: Visceral adipose tissue production and liver metabolism. Diabetes Metab. 2008; 34(5):439-45. DOI: 10.1016/j.diabet.2008.04.002. View

Scheller E, Rosen C . What's the matter with MAT? Marrow adipose tissue, metabolism, and skeletal health. Ann N Y Acad Sci. 2014; 1311:14-30. PMC: 4049420. DOI: 10.1111/nyas.12327. View

Eringa E, Bakker W, Smulders Y, Serne E, Yudkin J, Stehouwer C . Regulation of vascular function and insulin sensitivity by adipose tissue: focus on perivascular adipose tissue. Microcirculation. 2007; 14(4-5):389-402. DOI: 10.1080/10739680701303584. View

Collins D, Hogan A, OShea D, Winter D . The omentum: anatomical, metabolic, and surgical aspects. J Gastrointest Surg. 2009; 13(6):1138-46. DOI: 10.1007/s11605-009-0855-1. View

Grundy S, Adams-Huet B, Vega G . Variable contributions of fat content and distribution to metabolic syndrome risk factors. Metab Syndr Relat Disord. 2008; 6(4):281-8. PMC: 3190266. DOI: 10.1089/met.2008.0026. View

Houben A, Eringa E, Jonk A, Serne E, Smulders Y, Stehouwer C . Perivascular Fat and the Microcirculation: Relevance to Insulin Resistance, Diabetes, and Cardiovascular Disease. Curr Cardiovasc Risk Rep. 2012; 6(1):80-90. PMC: 3251783. DOI: 10.1007/s12170-011-0214-0. View

Lafontan M, Girard J . Impact of visceral adipose tissue on liver metabolism. Part I: heterogeneity of adipose tissue and functional properties of visceral adipose tissue. Diabetes Metab. 2008; 34(4 Pt 1):317-27. DOI: 10.1016/j.diabet.2008.04.001. View

10.

Feuerer M, Herrero L, Cipolletta D, Naaz A, Wong J, Nayer A . Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med. 2009; 15(8):930-9. PMC: 3115752. DOI: 10.1038/nm.2002. View

11.

Suchacki K, Tavares A, Mattiucci D, Scheller E, Papanastasiou G, Gray C . Bone marrow adipose tissue is a unique adipose subtype with distinct roles in glucose homeostasis. Nat Commun. 2020; 11(1):3097. PMC: 7303125. DOI: 10.1038/s41467-020-16878-2. View

12.

Koska J, Stefan N, Votruba S, Smith S, Krakoff J, Bunt J . Distribution of subcutaneous fat predicts insulin action in obesity in sex-specific manner. Obesity (Silver Spring). 2008; 16(9):2003-9. PMC: 2692524. DOI: 10.1038/oby.2008.292. View

13.

Lastra G, Manrique C . Perivascular adipose tissue, inflammation and insulin resistance: link to vascular dysfunction and cardiovascular disease. Horm Mol Biol Clin Investig. 2015; 22(1):19-26. DOI: 10.1515/hmbci-2015-0010. View

14.

Rittig K, Staib K, Machann J, Bottcher M, Peter A, Schick F . Perivascular fatty tissue at the brachial artery is linked to insulin resistance but not to local endothelial dysfunction. Diabetologia. 2008; 51(11):2093-9. DOI: 10.1007/s00125-008-1128-3. View

15.

Vijay J, Gauthier M, Biswell R, Louiselle D, Johnston J, Cheung W . Single-cell analysis of human adipose tissue identifies depot and disease specific cell types. Nat Metab. 2020; 2(1):97-109. PMC: 7025882. DOI: 10.1038/s42255-019-0152-6. View

16.

Walker G, Verti B, Marzullo P, Savia G, Mencarelli M, Zurleni F . Deep subcutaneous adipose tissue: a distinct abdominal adipose depot. Obesity (Silver Spring). 2007; 15(8):1933-43. DOI: 10.1038/oby.2007.231. View

17.

Yu S, Kim W, Kim D, Yoon J, Lee K, Kim J . Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Medicine (Baltimore). 2015; 94(48):e2159. PMC: 4674200. DOI: 10.1097/MD.0000000000002159. View

18.

Monzon J, Basile R, Heneghan S, Udupi V, Green A . Lipolysis in adipocytes isolated from deep and superficial subcutaneous adipose tissue. Obes Res. 2002; 10(4):266-9. DOI: 10.1038/oby.2002.36. View

19.

Palau N, Rebuffat S, Altirriba J, Piquer S, Hanzu F, Gomis R . Role of IGFBP-3 in the regulation of β-cell mass during obesity: adipose tissue/β-cell cross talk. Endocrinology. 2011; 153(1):177-87. DOI: 10.1210/en.2011-0181. View

20.

Decaris M, Li K, Emson C, Gatmaitan M, Liu S, Wang Y . Identifying nonalcoholic fatty liver disease patients with active fibrosis by measuring extracellular matrix remodeling rates in tissue and blood. Hepatology. 2016; 65(1):78-88. PMC: 5516243. DOI: 10.1002/hep.28860. View